Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008914:Minoxidil / Q000627:therapeutic use*; D018377:Neurotransmitter Agents / Q000097:blood*; D009599:Nitroprusside / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use*
D018377:Neurotransmitter Agents; D011743:Pyrimidines; D009599:Nitroprusside; D006830:Hydralazine; D008914:Minoxidil